Background. New tools to better monitor dynamics of human immunodeficiency virus (HIV)
transmission are needed. Methods. National surveillance of newly HIV diagnoses included …

To increase the knowledge about S. capitis in the neonatal setting, we conducted a nationwide
3-month survey in 38 neonatal intensive care units (NICUs) covering 56.6% of French …

En 2012, 8% des sérologies VIH ont été réalisées dans un cadre anonyme et gratuit, et la
proportion de sérologies positives était plus élevée parmi les sérologies anonymes (3, 5‰) …

En 2009, l’Institut de veille sanitaire a initié la première enquête de séro prévalence pour le
VIH auprès des hommes ayant des rapports sexuels avec des hommes (HSH) fréquentant …

Cases of myocarditis and pericarditis have been reported following the receipt of Covid-19
mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a …

Background Routine national incidence testing with enzyme immunoassay for recent HIV-1
infections (EIA-RI) has been done in France since January, 2003. From the reported number …

Bivalent Vaccination and Cardiovascular Risks In this French study, the risk of
cardiovascular events was similar among recipients of the bivalent vaccine and the original …

Background In France, roughly 40,000 HIV-infected persons are unaware of their HIV infection.
Although previous studies have evaluated the cost-effectiveness of routine HIV screening …

Background: The BNT162b2 (Pfizer–BioNTech) vaccine has been shown to be safe with
regard to risk for severe cardiovascular events (such as myocardial infarction [MI], pulmonary …

Assessment of the cumulative incidence of SARS-CoV-2 infections is critical for monitoring
the course and extent of the COVID-19 epidemic. Here, we report estimated seroprevalence …